
How much does the U.S. pharmaceutical supply chain depend on China?
During the COVID-19 pandemic, concern arose over the U.S.’s dependence on China for essential medicines. Trump ordered in 2020 to prioritize the domestic production of these medicines. The exposure to Chinese products is less than 25% in volume of active pharmaceutical ingredients. Understanding this dependence is crucial for supply policy and resilience.



